You are using an older browser version. Please use a supported version for the best MSN experience.

Sage Therapeutics CEO: Getting the first postpartum depression drug approved

Jim Cramer talks with Sage Therapeutics CEO Jeff Jonas about the biopharma company's Zulresso drug for postpartum depression and how it could help mothers.
image beaconimage beaconimage beacon